Young Breast Cancer Patients Deserve to Know If They Need Chemotherapy or Not #NoMatterMyAge

Share it with your friends Like

Thanks! Share it with your friends!


Breast cancer is the most common cancer in young women, yet most of these women don’t have all the information they need about their diagnosis, including a genomic test result. In fact, genomic testing rates in patients under 40 decrease 1.5-fold compared to older patients. The No Matter My Age campaign focuses on raising awareness about the need for all breast cancer patients, regardless of age, to get as much information as they can before making a treatment decision. This means having an open conversation with your doctor and asking questions about your care, including whether a genomic test may help determine the best treatment plan for you. Learn more at


Write a comment